HOME › DRUGS › OCTREOTIDE
ACTIVE SUBSTANCE / INN

OCTREOTIDE

Brand name(s): Oczyesa, Mycapssa
EMA LISTED
WITHDRAWN
AUTHORISED
Acromegaly
ACTIVE SUBSTANCE
Octreotide
REGULATORS
EMA
SPONSORS / MAH
Amryt Pharmaceuticals DAC, Camurus AB
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OczyesaCamurus ABAuthorised30/06/2025Acromegaly
MycapssaAmryt Pharmaceuticals DACWithdrawn02/12/2022Acromegaly

FULL INTELLIGENCE ON OCTREOTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →